McN5652 is a molecule that can be radiolabeled and then used as a radioligand in positron emission tomography (PET) studies. The [11C]-(+)-McN5652 enantiomer...
5 KB (378 words) - 19:45, 20 December 2023
approved, dapoxetine will be marketed in the US by Ortho McNeil pharmaceutical, Inc. Ortho McNeil and Janssen-Ortho Inc, or Janssen-Cilag are all units...
28 KB (3,079 words) - 01:49, 23 May 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
18 KB (1,430 words) - 14:54, 2 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
6 KB (418 words) - 04:31, 25 July 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
28 KB (2,348 words) - 01:40, 22 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
21 KB (1,819 words) - 07:18, 18 July 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
22 KB (1,721 words) - 05:27, 7 May 2024
hdl:2445/130480. PMID 30738029. S2CID 73433868. Duart-Castells L, Blanco-Gandía MC, Ferrer-Pérez C, Puster B, Pubill D, Miñarro J, et al. (June 2020). "Cross-reinstatement...
34 KB (3,319 words) - 19:30, 3 August 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
12 KB (879 words) - 03:18, 26 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
17 KB (1,484 words) - 13:54, 8 August 2024
the original on 3 March 2021. Retrieved 3 March 2021 – via GlobeNewswire. McCuistion LE, Yeager JJ, Winton MB, DiMaggio K (2021). "Chapter 18: Stimulants"...
7 KB (354 words) - 12:59, 22 June 2024
2024. Retrieved 29 December 2023. Ketamine is listed in Schedule III. Huang, MC., Lin, SK. (2020). "Ketamine Abuse: Past and Present". In: Hashimoto, K.,...
117 KB (11,360 words) - 02:18, 14 September 2024
subsidiaries, Johnson & Johnson Pharmaceutical Research and Development and Ortho-McNeil Pharmaceutical to develop and market tapentadol; Johnson & Johnson had...
35 KB (3,372 words) - 20:43, 21 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
21 KB (1,711 words) - 17:59, 7 September 2024
(May 2019). "Deutetrabenazine Therapy and CYP2D6 Genotype". In Pratt VM, McLeod HL, Rubinstein WS, et al. (eds.). Medical Genetics Summaries. National...
9 KB (652 words) - 03:18, 26 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
39 KB (3,518 words) - 17:47, 7 September 2024
43597. PMC 9685490. PMID 36416824. Liang EF, Lim SZ, Tam WW, Ho CS, Zhang MW, McIntyre RS, et al. (August 2018). "The Effect of Methylphenidate and Atomoxetine...
149 KB (13,792 words) - 07:18, 26 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
7 KB (630 words) - 08:12, 26 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
24 KB (1,915 words) - 10:08, 20 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
16 KB (1,763 words) - 00:25, 18 September 2024
1093/ijnp/pyu001. PMC 4368859. PMID 25539501. Cheng MH, Block E, Hu F, Cobanoglu MC, Sorkin A, Bahar I (2015). "Insights into the Modulation of Dopamine Transporter...
181 KB (19,541 words) - 07:13, 25 September 2024
1211/0022357991772303. PMID 10344632. S2CID 31845784. Cheng MH, Block E, Hu F, Cobanoglu MC, Sorkin A, Bahar I (2015). "Insights into the Modulation of Dopamine Transporter...
18 KB (1,550 words) - 21:52, 16 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
77 KB (7,766 words) - 08:12, 27 September 2024
Emtricitabine/rilpivirine/tenofovir K-Y Jelly Levaquin Lomotil Loperamide McN5652 Methylphenidate Ofloxacin Opsumit Micronor Mylanta Mylicon Natrecor Nizoral...
7 KB (764 words) - 16:32, 18 September 2024
1001/jamainternmed.2014.1891. PMC 4179877. PMID 24861828. Redrobe JP, Bourin M, Colombel MC, Baker GB (July 1998). "Dose-dependent noradrenergic and serotonergic properties...
79 KB (7,725 words) - 03:02, 24 September 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
4 KB (281 words) - 17:21, 25 January 2024
(tomoxetine) CP-39,332 Desvenlafaxine Duloxetine Eclanamine Levomilnacipran McN5652 Milnacipran N-Methyl-PPPA Nafenodone PPPA Tofenacin Venlafaxine...
16 KB (1,623 words) - 01:29, 17 September 2024
Goodman and Gilman's The Pharmacological Basis of Therapeutics (Twelfth ed.). McGraw Hill Professional. ISBN 978-0-07-176939-6. Obach RS, Walsky RL, Venkatakrishnan...
102 KB (10,567 words) - 23:29, 20 September 2024
2012.674110. PMID 22550944. S2CID 32144885. Benvenuto A, Battan B, Porfirio MC, Curatolo P (February 2013). "Pharmacotherapy of autism spectrum disorders"...
117 KB (11,688 words) - 20:57, 15 September 2024
University Press. ISBN 978-0-521-17364-3. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, et al. (June 2009). "Lack of efficacy of...
48 KB (4,601 words) - 20:57, 4 September 2024